Cocaine addiction persists as a problem of national significance. The goals of this project are to develop a fundamental understanding of the targets of cocaine in the brain at the molecular level and use this information to investigate the therapeutic potential of drugs that bind to these targets. Accumulating evidence suggests that the dopamine transporter is a principal mediator of cocaine in the brain. Current models propose that the binding of cocaine and dopamine to the transporter requires the formation of an ionic bond between a basic amine nitrogen of the ligand and a counterion (aspartic acid) on the transporter. To explore this premise, we developed non-amine ( nonamines ) nitrogen bearing cocaine analogs (aryloxatropanes). These nonamines bind with high affinity to monamine transporters and block dopamine transport in COS-7 cell and engender cocaine-like subjective effects in monkeys. The findings invalidate the premise that transporter drugs require an amine nitrogen. We will determine the structure-activity relationships of nonamines at monoamine transporters in brain. High affinity nonamines will be tested in cell lines expressing wild-type and in mutant forms of the transporter in which the aspartic acid counterion is exchanged for other amino acids. The most promising compound(s) will be radiolabled for further investigation of the binding domains on monoamine transporters. These unique nonamines will increase our understanding of drug-transporter interactions and open avenues for discovery of a new generation of drugs targeted to monamine transporters. To explore the potential of nonamines and their nitrogen-bearing counterparts as cocaine replacement therapy, we will investigate their ability to mimic the subjective effects of cocaine, determine whether they maintain i.v. self-administration, which is predictive of compound's abuse liability, and determine the degree to which they modify the self-administration of cocaine, which is predictive of their therapeutic utility as a cocaine replacement. Our multidisciplinary approach to cocaine research will provide fundamental information on the neurobiology of cocaine with direct relevance to cocaine medications.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DA006303-11
Application #
6164437
Study Section
Special Emphasis Panel (ZDA1-GXD-C (07))
Program Officer
Kline, Richard
Project Start
1989-09-30
Project End
2003-02-28
Budget Start
2000-03-01
Budget End
2001-02-28
Support Year
11
Fiscal Year
2000
Total Cost
$288,096
Indirect Cost
Name
Harvard University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Torun, Lokman; Madras, Bertha K; Meltzer, Peter C (2012) Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters. Bioorg Med Chem 20:2762-72
Purushotham, Madhusudhan; Sheri, Anjaneyulu; Pham-Huu, Duy-Phong et al. (2011) The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes. Bioorg Med Chem Lett 21:48-51
Vallender, Eric J; Lynch, Laurie; Novak, Melinda A et al. (2009) Polymorphisms in the 3' UTR of the serotonin transporter are associated with cognitive flexibility in rhesus macaques. Am J Med Genet B Neuropsychiatr Genet 150B:467-75
Vallender, E J; Priddy, C M; Hakim, S et al. (2008) Functional variation in the 3'untranslated region of the serotonin transporter in human and rhesus macaque. Genes Brain Behav 7:690-7
Xie, Zhihua; Miller, Gregory M (2008) Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. J Pharmacol Exp Ther 325:617-28
Xie, Zhihua; Vallender, Eric J; Yu, Naichen et al. (2008) Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association. J Neurosci Res 86:3435-46
Verrico, Christopher D; Lynch, Laurie; Fahey, Michele A et al. (2008) MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. J Psychopharmacol 22:187-202
Vallender, Eric J; Priddy, Cassandra M; Chen, Guo-Lin et al. (2008) Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque. Behav Genet 38:390-5
Xie, Zhihua; Westmoreland, Susan V; Miller, Gregory M (2008) Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther 325:629-40
Xie, Zhihua; Westmoreland, Susan V; Bahn, Mary E et al. (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321:116-27

Showing the most recent 10 out of 73 publications